Survodutide
A Study to Test Different Doses of BI 456906 in Patients With Obesity
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 131
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| BI 456906 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.